Loading resource…

American Academy of Neurology
The document systematically reviews literature from January 2008 to April 2020 to classify evidence and develop practice recommendations for treating painful diabetic neuropathy (PDN). It discusses various treatment options, including gabapentinoids, serotonin-norepinephrine reuptake inhibitors, and sodium channel blockers, highlighting their efficacy and potential side effects. The recommendations aim to guide clinicians in selecting appropriate interventions for managing PDN effectively.
No account needed